Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty - Top-Institutions - MDSpire

Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty

  • By

  • Ce Huang

  • Yingqian Zhu

  • Xue Gong

  • Shengyu Feng

  • Guangying Huo

  • Hailiang Liu

  • Hua Jiang

  • Zhongmin Liu

  • July 13, 2026

Share

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

  • #1

    Shanghai East Hospital
    Shanghai East Hospital

    Shanghai, Shanghai

    Key Differentiators

    • Immunology

  • #2

    Karolinska Institute
    Karolinska Institute

    Stockholm, Sweden

    Key Differentiators

    • Immunology

  • #3

    European Society for Blood and Marrow Transplantation
    European Society for Blood and Marrow Transplantation

    N/A, N/A

    Key Differentiators

    • Immunology

  • #4

    Autoimmune Diseases Working Party
    Autoimmune Diseases Working Party

    N/A, N/A

    Key Differentiators

    • Immunology

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Immunology

Original Source(s)

Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty

  • by Ce Huang, Yingqian Zhu, Xue Gong, Shengyu Feng, Guangying Huo, Hailiang Liu, Hua Jiang, Zhongmin Liu

  • July 13, 2026

Related Content

The mediating role of testosterone in the relationship between body fat percentage and diabetes mellitus risk

Serum and urinary golgi membrane protein 1 (GOLM1/GP73/G73) for chronic kidney disease staging

Effects of statins on functional capacity and cardiac remodeling in patients with heart failure and preserved ejection fraction: a randomized open-label pilot trial